Blueprint Investment Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,163
Closed -$215K 166
2024
Q4
$215K Buy
2,163
+148
+7% +$15.3K 0.03% 184
2024
Q3
$229K Sell
2,015
-9,881
-83% -$1.17M 0.04% 154
2024
Q2
$1.47M Buy
11,896
+1,335
+13% +$172K 0.32% 48
2024
Q1
$1.39M Buy
10,561
+6,378
+152% +$786K 0.28% 49
2023
Q4
$456K Sell
4,183
-3,099
-43% -$322K 0.13% 74
2023
Q3
$750K Sell
7,282
-4,475
-38% -$482K 0.24% 53
2023
Q2
$1.36M Sell
11,757
-3,561
-23% -$404K 0.49% 36
2023
Q1
$1.63M Sell
15,318
-2,702
-15% -$292K 0.37% 58
2022
Q4
$2M Buy
18,020
+1,027
+6% +$105K 0.42% 50
2022
Q3
$1.46M Buy
16,993
+2,688
+19% +$240K 0.4% 48
2022
Q2
$1.3M Buy
14,305
+10,555
+281% +$936K 0.35% 49
2022
Q1
$308K Sell
3,750
-3,764
-50% -$297K 0.08% 136
2021
Q4
$576K Buy
+7,514
New +$598K 0.14% 114

Other funds holding MRK

Blueprint Investment Partners's MRK Position: Q1 2025 in Review

Blueprint Investment Partners sold out of Merck (MRK) in Q1 2025, closing a stake of 2,163 shares — an estimated $215K sold.

Blueprint Investment Partners first reported a position in MRK in Q4 2021 and held it in 13 quarters. The position peaked at $2M in Q4 2022. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Blueprint Investment Partners reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Blueprint Investment Partners sold 2,163 Merck shares in Q1 2025, an estimated $215K.
  • Blueprint Investment Partners first reported a position in Merck in Q4 2021 and held it in 13 quarters.
  • Blueprint Investment Partners's Merck position peaked at $2M in Q4 2022.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Blueprint Investment Partners's 13F filing for Q1 2025, filed 12 May 2025.